FIELD: medicinal industry.
SUBSTANCE: the present innovation deals with manufacturing medicinal preparation containing drotaverin hydrochloride to be applied for interrupting spasms of smooth musculature. Mass for tableting should be prepared due to mixing the powder of drotaverin hydrochloride with that of dyed granulate at the ratio of 1:3 to 2:1. One should obtain the dyed granulate by moisturizing inert pharmaceutical filler with binder's solution dyed with quinoline yellow dyestuff. Then comes drying up to 0.1-2.5% followed by granulation and tableting. The innovation enables to obtain tablets of drotaverin hydrochloride upon industrial equipment at its degradability being below 15 min, being stable during manufacturing and at storage. Quality of tablets meets all the requirements of pharmacopoeic article.
EFFECT: higher efficiency of manufacturing.
2 cl, 4 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
SPASMOLYTIC MEDICINAL AGENT | 2002 |
|
RU2232018C2 |
METHOD OF ANTIANGINAL MEDICINAL AGENT PREPARING | 2000 |
|
RU2195932C2 |
PHARMACEUTICAL COMPOSITION SHOWING SPASMOLYTIC ACTIVITY, METHOD OF ITS PREPARING | 2001 |
|
RU2183119C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANALGETIC, ANTI-INFLAMMATORY, ANTIPYRETIC AND SPASMOLYTIC EFFECT | 2001 |
|
RU2183116C1 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
SOLID DOSAGE FORM OF CLOPIDOGREL AND METHOD FOR PREPARING THEREOF | 2009 |
|
RU2393862C1 |
METHOD FOR PREPARING ANTIBACTERIAL MEDICINAL AGENT | 2002 |
|
RU2224517C1 |
RAPIDLY DISSOLVING DOSAGE FORM OF FURAZOLIDONE AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772430C1 |
PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
Authors
Dates
2005-05-20—Published
2003-04-22—Filed